Ligand-target prediction using Winnow and naive Bayesian algorithms and the implications of overall performance statistics.
We compared two algorithms for ligand-target prediction, namely, the Laplacian-modified Bayesian classifier and the Winnow algorithm. A dataset derived from the WOMBAT database, spanning 20 pharmaceutically relevant activity classes with 13 000 compounds, was used for performance assessment in 24 different experiments, each of which was assessed using a 15-fold Monte Carlo cross-validation. Compounds were described by different circular fingerprints, ECFP_4 and MOLPRINT 2D. A detailed analysis of the resulting approximately 2.4 million predictions led to very similar measures for overall accuracy for both classifiers, whereas we observed significant differences for individual activity classes. Moreover, we analyzed our data with respect to the numbers of compounds which are exclusively retrieved by either of the algorithmsbut never by the otheror by neither of them. This provided detailed information that can never be obtained by considering the overall performance statistics alone.
Nigsch
Florian
F
Unilever Centre for Molecular Science Informatics, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.
Bender
Andreas
A
Jenkins
Jeremy L
JL
Mitchell
John B O
JB
D000465:Algorithms; D001499:Bayes Theorem; D016203:CDC2 Protein Kinase / Q000378:metabolism; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5 / Q000378:metabolism; D019926:Cyclin B / Q000378:metabolism; D016208:Databases, Factual; D015195:Drug Design; D055808:Drug Discovery / Q000145:classification / Q000379:methods / Q000706:statistics & numerical data*; D004353:Drug Evaluation, Preclinical; D008024:Ligands; D009010:Monte Carlo Method; D014584:User-Computer Interface
D019926:Cyclin B; D008024:Ligands; D016203:CDC2 Protein Kinase; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5